Cargando…
In vitro proof of concept studies of radiotoxicity from Auger electron-emitter thallium-201
BACKGROUND: Auger electron-emitting radionuclides have potential in targeted treatment of small tumors. Thallium-201 ((201)Tl), a gamma-emitting radionuclide used in myocardial perfusion scintigraphy, decays by electron capture, releasing around 37 Auger and Coster–Kronig electrons per decay. Howeve...
Autores principales: | Osytek, Katarzyna M., Blower, Philip J., Costa, Ines M., Smith, Gareth E., Abbate, Vincenzo, Terry, Samantha Y. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257813/ https://www.ncbi.nlm.nih.gov/pubmed/34224019 http://dx.doi.org/10.1186/s13550-021-00802-w |
Ejemplares similares
-
Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals
por: Rigby, Alex, et al.
Publicado: (2021) -
Toward Bifunctional Chelators for Thallium-201 for
Use in Nuclear Medicine
por: Rigby, Alex, et al.
Publicado: (2022) -
Tracing chameleon: thallium-201 SPECT/CT for pheochromocytoma
por: Wang, Yuh-Feng, et al.
Publicado: (2008) -
In vitro cytotoxicity of Auger electron-emitting [(67)Ga]Ga-trastuzumab
por: Othman, Muhamad Faiz bin, et al.
Publicado: (2020) -
Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron Emitters
por: Sobolev, Alexander S.
Publicado: (2018)